Development of etoricoxib-loaded mesoporous silica nanoparticles laden gel as vehicle for transdermal delivery: optimization, <i>ex vivo</i> permeation, histopathology, and <i>in vivo</i> anti-inflammatory study
Based on the findings, the results suggest that the MSNPs gel has the potential as a carrier for enhancing the therapeutic efficacy of ETB through topical delivery, although further studies are needed to fully confirm its effectiveness.
Authors
- Dibyalochan Mohanty (ORCID: https://orcid.org/0000-0002-1895-8706)
- Gnyana Ranjan Parida (ORCID: https://orcid.org/0000-0001-5663-8474)
- N. G. Divya
- Musarrat Husain Warsi (ORCID: https://orcid.org/0000-0002-9071-8889)
- Ameeduzzafar Zafar
- Mohd Yasir (ORCID: https://orcid.org/0000-0001-9742-1482)
- Mohammad Khalid (ORCID: https://orcid.org/0000-0002-2163-0066)
- Md Ali Mujtaba (ORCID: https://orcid.org/0000-0002-6372-890X)
- P. Padhi
Institutions
- Northern Border University (SA)
- Prince Sattam Bin Abdulaziz University (SA)
- Taif University (SA)
- Jouf University (SA)
- The Centre for Health (New Zealand) (NZ)
- Institute of Science and Technology
- Arsi University
- Centurion University of Technology and Management (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1080/03639045.2025.2490287
- Citations
- 6
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 4.74